Back
Nabors Industries 10K Form
Sell
29
NBR
Nabors Industries
Last Price:
$52.94
Seasonality Move:
12.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | NBR/Nabors Industries Quarterly |
2024-02-12 | 10K | NBR/Nabors Industries Annual |
2023-10-27 | 10Q | NBR/Nabors Industries Quarterly |
2023-07-28 | 10Q | NBR/Nabors Industries Quarterly |
2023-04-27 | 10Q | NBR/Nabors Industries Quarterly |
2023-02-09 | 10K | NBR/Nabors Industries Annual |
Receive NBR News And Ratings
See the #1 stock for the next 7 days that we like better than NBR
NBR Financial Statistics
Sales & Book Value
Annual Sales: | $3B |
---|---|
Cash Flow: | $15.7M |
Price / Cash Flow: | 4.04 |
Annual Sales: | $20.04 |
Price / Book: | 2.64 |
Profitability
EPS (TTM): | -18.39000 |
---|---|
Net Income (TTM): | $-139.1M |
Gross Margin: | $570.3M |
Return on Equity: | -10.81% |
Return on Assets: | -2.92% |
Nabors Industries Earnings Forecast
Key Nabors Industries Financial Ratios
-
The Gross Profit Margin over the past 40 years for NBR is 18.97%.
-
The Selling, General & Administrative Expenses for NBR have been equal to 8.12% of Gross Profit Margin.
-
The Research & Development expenses have been 1.87% of Revenue.
-
The Interest Expense is -1,572.34% of Operating Income.
-
The Net Earning history of NBR is -0.39% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 22 years.
Nabors Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Energy Equipment & Services |
Sector: | Energy |
Current Symbol: | NBR |
CUSIP: | G6359F |
Website: | nabors.com |
Debt
Debt-to-Equity Ratio: | 13.08 |
---|---|
Current Ratio: | 1.88 |
Quick Ratio: | 1.48 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NBR Technical Analysis vs Fundamental Analysis
Sell
29
Nabors Industries (NBR)
is a Sell
Is Nabors Industries a Buy or a Sell?
-
Nabors Industries stock is rated a SellThe current Nabors Industries [NBR] share price is $52.96. The Score for NBR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.